港股異動丨映客(3700.HK)漲7% 改名映宇宙全面向元宇宙進軍
格隆匯6月16日丨映客(3700.HK)午後拉昇漲7%,報1.52港元,暫成交1928萬港元,總市值29.3億港元。6月15日,映客宣佈品牌和戰略方向全新升級。映客互娛集團正式更名為映宇宙(英文名稱Inkeverse),業務全面向元宇宙進軍,並簽約虛擬人“映映”為映宇宙品牌代言人。映客“社交+元宇宙”新玩法,或許會給行業帶來新的啟發。東吳證券認為其通過社交賽道切入元宇宙具有一定優勢,期待後續發展。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.